Welcome, fellow explorers of the mind-body connection! 🧠🦠 In this in-depth article, we're embarking on a journey through the fascinating and complex interplay between depression, the gut microbiome, inflammation, and serotonin production. This isn't just another health topic—it's a deep dive into how your gut's tiny inhabitants might be influencing your mood, emotions, and overall mental well-being. Get ready to uncover the science, history, and practical insights that could transform your understanding of mental health!

Introduction: The Hidden Threads of Mental Health

Depression affects millions worldwide, often leaving individuals feeling isolated and misunderstood. But what if the roots of this condition extend far beyond the brain—into the gut? Recent scientific discoveries are revealing that the gut microbiome, inflammation, and serotonin production are intricately linked, forming a complex web that influences mental health in profound ways.

In this comprehensive article, we'll explore:

  • The historical evolution of understanding depression and its biological underpinnings
  • The mechanisms connecting the gut microbiome to brain function
  • How inflammation acts as a bridge between gut health and mood disorders
  • The critical role of serotonin production in mental well-being
  • Current research findings and their implications
  • Clinical applications and therapeutic strategies

By the end, you'll have a thorough understanding of this multifaceted connection and practical steps you can take to support your mental health through gut wellness.

Historical Context: From Humors to Microbiome

Ancient Views on Depression and Mood

The story of depression and mental health begins thousands of years ago. In ancient civilizations, mood disorders were often attributed to imbalances in bodily fluids or "humors." The Greek physician Hippocrates (460-370 BCE) described melancholia as a condition caused by an excess of black bile, which was thought to affect the brain and cause sadness, lethargy, and despair.

This humoral theory persisted through the Middle Ages and into the Renaissance. During the 17th century, English physician Thomas Willis began to explore the brain's role in mental disorders, laying early groundwork for modern neurology. However, it wasn't until the 20th century that significant breakthroughs would connect mental health to specific biological mechanisms.

The Serotonin Revolution

The modern understanding of depression took a giant leap forward in the 1950s with the discovery of serotonin. In 1948, Italian researchers Vittorio Erspamer and Betty Mack isolated serotonin from the gut, initially calling it "enteramine" due to its presence in the intestines. It wasn't until 1952 that its role in the brain was recognized.

The 1950s and 1960s saw the development of the first antidepressant medications, including monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs). These drugs worked by increasing serotonin and norepinephrine levels in the brain, giving rise to the "chemical imbalance" theory of depression.

However, this theory has been challenged in recent years as researchers discovered that depression is far more complex than simple neurotransmitter imbalances. The discovery of the gut-brain axis and the microbiome's role in mental health has opened up entirely new avenues of understanding.

The Microbiome Awakening

While the concept of gut bacteria influencing health dates back to the early 20th century (Élie Metchnikoff's work on probiotics in 1907), the modern microbiome era began in the 2000s with the advent of high-throughput DNA sequencing. The Human Microbiome Project, launched in 2007, revolutionized our understanding of the trillions of microorganisms living in and on our bodies.

Key milestones in microbiome research include:

  • 2004: Jeffrey Gordon's lab publishes the first gut microbiome study linking bacteria to obesity
  • 2011: First studies emerge connecting gut bacteria to brain function and behavior
  • 2013: The term "psychobiotic" is coined to describe probiotics that confer mental health benefits
  • 2019: Major review in Physiological Reviews establishes the microbiota-gut-brain axis as a key research area

This historical journey from ancient humors to modern microbiome science sets the stage for understanding the complex interplay between depression, inflammation, and serotonin production.

The Gut-Brain Axis: Communication Highway of the Body

Understanding the Gut-Brain Connection

The gut-brain axis is a bidirectional communication system between the gastrointestinal tract and the central nervous system. This complex network involves multiple pathways:

  1. Neural Pathways: The vagus nerve, the longest cranial nerve, serves as a direct communication line between the gut and brain
  2. Hormonal Pathways: Gut hormones like ghrelin and leptin influence brain function
  3. Immune Pathways: The gut-associated lymphoid tissue (GALT) communicates with the brain via cytokines
  4. Microbial Pathways: Gut bacteria produce metabolites that affect brain chemistry

The Microbiome's Role in Brain Function

Your gut microbiome consists of approximately 100 trillion microorganisms, including bacteria, viruses, fungi, and archaea. These tiny organisms play crucial roles in:

  • Metabolite Production: Bacteria break down dietary components into short-chain fatty acids (SCFAs), neurotransmitters, and other bioactive compounds
  • Immune Regulation: Gut bacteria train the immune system and maintain immune homeostasis
  • Barrier Function: Beneficial bacteria help maintain the integrity of the gut lining
  • Neurotransmitter Synthesis: Certain gut bacteria can produce or influence the production of neurotransmitters like serotonin, dopamine, and GABA

How Gut Dysbiosis Affects Mental Health

When the gut microbiome is imbalanced—a condition known as dysbiosis—it can have far-reaching effects on mental health:

  • Increased Inflammation: Dysbiotic gut bacteria can trigger systemic inflammation that affects the brain
  • Altered Neurotransmitter Production: Changes in gut bacteria can disrupt the synthesis of mood-regulating neurotransmitters
  • Stress Response Dysregulation: The gut microbiome influences the hypothalamic-pituitary-adrenal (HPA) axis, which controls stress responses
  • Blood-Brain Barrier Disruption: Gut dysbiosis can compromise the blood-brain barrier, allowing harmful substances to enter the brain

Inflammation: The Bridge Between Gut and Mind

The Inflammatory Basis of Depression

In recent years, inflammation has emerged as a key player in the development and progression of depression. This connection is so significant that some researchers have proposed "inflammatory depression" as a subtype of major depressive disorder.

Mechanisms of Inflammation in Depression

  1. Cytokine-Induced Sickness Behavior: Pro-inflammatory cytokines like interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and interferon-gamma (IFN-γ) can induce symptoms similar to depression, including fatigue, anhedonia, and social withdrawal.

  2. Neuroinflammation: Chronic inflammation can lead to neuroinflammation, damaging brain cells and disrupting neural circuits involved in mood regulation.

  3. Tryptophan Metabolism Disruption: Inflammation activates the enzyme indoleamine 2,3-dioxygenase (IDO), which diverts tryptophan away from serotonin production toward the kynurenine pathway, potentially leading to depressive symptoms.

  4. Blood-Brain Barrier Permeability: Inflammatory processes can increase blood-brain barrier permeability, allowing inflammatory molecules to enter the brain and cause damage.

The Gut-Inflammation-Depression Connection

The gut microbiome plays a crucial role in regulating inflammation:

  • Beneficial Bacteria: Species like Bifidobacterium and Lactobacillus produce anti-inflammatory compounds and help maintain gut barrier integrity
  • Pathogenic Bacteria: Overgrowth of harmful bacteria can increase gut permeability (leaky gut), allowing toxins and bacteria into the bloodstream, triggering systemic inflammation
  • Short-Chain Fatty Acids: Gut bacteria produce SCFAs like butyrate, which have anti-inflammatory effects and support brain health
  • Microbial Diversity: A diverse microbiome is associated with lower inflammation and better mental health outcomes

Clinical Evidence for Inflammation in Depression

Several studies have demonstrated elevated inflammatory markers in depressed individuals:

  • A 2013 meta-analysis found that depressed patients had significantly higher levels of C-reactive protein (CRP), IL-6, and TNF-α compared to healthy controls
  • The Netherlands Study of Depression and Anxiety (NESDA) found that higher baseline inflammation predicted the onset of depression over a 6-year follow-up period
  • Treatment with anti-inflammatory drugs has shown promise in reducing depressive symptoms in some patients

Serotonin Production: The Gut-Brain-Serotonin Axis

Serotonin's Central Role in Mental Health

Serotonin, often called the "feel-good" neurotransmitter, plays crucial roles in:

  • Mood regulation
  • Sleep-wake cycles
  • Appetite control
  • Pain perception
  • Social behavior
  • Cognitive function

Surprisingly, about 95% of the body's serotonin is produced in the gut, not the brain. This makes the gut a primary site for serotonin synthesis and regulation.

The Serotonin Production Pathway

Serotonin is synthesized from the amino acid tryptophan through a two-step process:

  1. Tryptophan Hydroxylation: Tryptophan is converted to 5-hydroxytryptophan (5-HTP) by the enzyme tryptophan hydroxylase
  2. Decarboxylation: 5-HTP is converted to serotonin by aromatic L-amino acid decarboxylase

Gut Microbiome's Influence on Serotonin Production

The gut microbiome affects serotonin production through multiple mechanisms:

  1. Tryptophan Availability: Gut bacteria can produce tryptophan or influence its absorption from food
  2. Enzyme Activity: Certain bacteria can modulate the activity of tryptophan-metabolizing enzymes
  3. Gut Barrier Integrity: A healthy gut barrier ensures proper nutrient absorption, including tryptophan
  4. Inflammation Regulation: By controlling inflammation, gut bacteria help maintain optimal conditions for serotonin synthesis
  5. Direct Production: Some gut bacteria may directly produce serotonin or serotonin precursors

Specific Bacterial Strains and Serotonin

Research has identified several bacterial strains that influence serotonin production:

  • Lactobacillus rhamnosus: Has been shown to increase serotonin receptor expression in the brain
  • Bifidobacterium infantis: May enhance tryptophan availability for serotonin synthesis
  • Escherichia coli: Some strains can convert tryptophan to serotonin
  • Streptococcus species: Certain strains produce serotonin directly

The Kynurenine Pathway: A Double-Edged Sword

The gut microbiome also influences the kynurenine pathway, which competes with serotonin production for tryptophan:

  • Beneficial Bacteria: Produce SCFAs that inhibit IDO activation, favoring serotonin production
  • Harmful Bacteria: Can activate IDO, diverting tryptophan to kynurenine, which can have neurotoxic effects
  • Inflammation: Triggers IDO activation, potentially reducing serotonin availability

Current Research: Breakthroughs and Ongoing Studies

Landmark Studies on Microbiome and Depression

  1. Jiang et al. (2015): This groundbreaking study found that patients with major depressive disorder had significantly different gut microbiota composition compared to healthy controls. Depressed individuals showed reduced diversity and altered abundance of specific bacterial taxa.

  2. Valles-Colomer et al. (2019): Published in Nature Microbiology, this study identified specific microbial signatures associated with quality of life and depression. The researchers found that certain bacterial species were consistently associated with better mental health outcomes.

  3. Kelly et al. (2016): This study demonstrated that transplanting fecal microbiota from depressed humans to rats induced depressive-like behaviors in the animals, providing causal evidence for the microbiome's role in depression.

  4. Foster and Neufeld (2013): This review article coined the term "psychobiotic" and outlined the potential of probiotics for mental health treatment.

Inflammation and Depression Research

  1. Miller and Raison (2016): This comprehensive review in Nature Reviews Immunology detailed the role of inflammation in depression and proposed that anti-inflammatory treatments could be effective for some depressed patients.

  2. Kappelmann et al. (2018): A meta-analysis of 24 studies found that higher levels of CRP were associated with increased risk of depression, particularly in women.

  3. Raison et al. (2013): This randomized controlled trial showed that infliximab, an anti-inflammatory drug, reduced depressive symptoms in patients with treatment-resistant depression who had high baseline inflammation.

Serotonin and Microbiome Studies

  1. Yano et al. (2015): This study discovered that certain gut bacteria can directly produce serotonin, challenging the notion that serotonin is only produced by host cells.

  2. O'Mahony et al. (2015): Research showing that Bifidobacterium infantis can normalize tryptophan metabolism and reduce depressive behaviors in animal models.

  3. Desbonnet et al. (2008): This study demonstrated that probiotics could reverse stress-induced changes in serotonin receptor expression in the brain.

Recent Advances and Ongoing Research

Current research is focusing on several promising areas:

  1. Personalized Psychobiotics: Developing probiotic formulations tailored to individual microbiome profiles
  2. Microbiome-Based Diagnostics: Using gut bacteria composition as biomarkers for depression risk and treatment response
  3. Fecal Microbiota Transplantation (FMT): Investigating the potential of FMT for treatment-resistant depression
  4. Microbiome-Targeted Diets: Developing specific dietary interventions to optimize gut bacteria for mental health
  5. Longitudinal Studies: Tracking microbiome changes over time in relation to mental health outcomes

Clinical Applications: From Research to Practice

Dietary Interventions

  1. Mediterranean Diet: Rich in fruits, vegetables, whole grains, and healthy fats, this diet supports beneficial gut bacteria and reduces inflammation
  2. Fermented Foods: Incorporating yogurt, kefir, sauerkraut, and kimchi to introduce beneficial bacteria
  3. Prebiotic-Rich Foods: Eating foods like garlic, onions, leeks, and asparagus to feed beneficial bacteria
  4. Omega-3 Fatty Acids: Found in fatty fish, flaxseeds, and walnuts, these have anti-inflammatory properties
  5. Polyphenol-Rich Foods: Berries, dark chocolate, and green tea contain compounds that support beneficial bacteria

Probiotic and Prebiotic Supplements

  1. Probiotics: Specific strains like Lactobacillus rhamnosus GG, Bifidobacterium longum, and Lactobacillus plantarum have shown promise for mental health
  2. Prebiotics: Inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS) can enhance beneficial bacteria growth
  3. Synbiotics: Combinations of probiotics and prebiotics for enhanced effects

Lifestyle Modifications

  1. Stress Management: Practices like meditation, yoga, and deep breathing can reduce inflammation and support gut health
  2. Exercise: Regular physical activity promotes beneficial bacteria growth and reduces inflammation
  3. Sleep Optimization: Quality sleep supports microbiome diversity and mental health
  4. Nature Exposure: Spending time outdoors can increase exposure to diverse microbes

Emerging Therapies

  1. Fecal Microbiota Transplantation (FMT): Transferring healthy gut bacteria to individuals with dysbiosis
  2. Psychobiotics: Probiotics specifically formulated for mental health benefits
  3. Microbiome-Targeted Drugs: Developing medications that work through the gut microbiome
  4. Anti-Inflammatory Treatments: Using anti-inflammatory drugs alongside traditional antidepressants

Clinical Guidelines and Recommendations

While microbiome-based treatments for depression are still emerging, several guidelines are being developed:

  1. Screening for Inflammation: Measuring inflammatory markers like CRP in depressed patients to identify those who might benefit from anti-inflammatory treatments
  2. Microbiome Assessment: Considering gut health evaluation as part of comprehensive mental health assessments
  3. Integrated Treatment Plans: Combining traditional therapies with microbiome-supporting interventions
  4. Monitoring and Follow-up: Regular assessment of both mental health symptoms and gut health markers

Challenges and Future Directions

Current Limitations

  1. Causality vs. Correlation: While associations between microbiome, inflammation, serotonin, and depression are clear, establishing causality remains challenging
  2. Individual Variability: The gut microbiome varies greatly between individuals, making personalized approaches necessary
  3. Standardization: Lack of standardized protocols for microbiome analysis and probiotic formulations
  4. Long-Term Effects: Limited data on the long-term effects of microbiome interventions for mental health

Future Research Directions

  1. Large-Scale Clinical Trials: Conducting rigorous, large-scale studies to validate microbiome-based treatments
  2. Mechanistic Studies: Further elucidating the specific mechanisms by which gut bacteria influence brain function
  3. Personalized Medicine: Developing algorithms to match individuals with optimal probiotic strains based on their microbiome profile
  4. Integration with Existing Treatments: Studying how microbiome interventions can enhance traditional antidepressant therapies
  5. Preventive Approaches: Investigating whether early microbiome optimization can prevent the onset of depression

Ethical Considerations

  1. Informed Consent: Ensuring patients understand the experimental nature of some microbiome interventions
  2. Data Privacy: Protecting sensitive microbiome data in research and clinical settings
  3. Access and Equity: Making microbiome-based treatments accessible to diverse populations
  4. Safety: Establishing long-term safety profiles for FMT and other microbiome interventions

Conclusion: A New Frontier in Mental Health

The intricate link between depression, the gut microbiome, inflammation, and serotonin production represents one of the most exciting frontiers in mental health research. We've journeyed from ancient theories of bodily humors to cutting-edge discoveries about the microbiome's profound influence on brain function.

Key takeaways from this exploration:

  1. The gut-brain axis is a bidirectional communication system that significantly influences mental health
  2. Inflammation serves as a critical bridge between gut dysbiosis and depressive symptoms
  3. Serotonin production is heavily influenced by gut bacteria and overall gut health
  4. Current research provides compelling evidence for the microbiome's role in depression
  5. Clinical applications are emerging, offering new hope for treatment and prevention

As we look to the future, the integration of microbiome science into mental health care promises to revolutionize our approach to depression and other mood disorders. By nurturing our gut health, we may be able to support not just our physical well-being, but our mental and emotional health as well.

Remember, while the science is compelling, it's important to approach these findings with both excitement and caution. The field is rapidly evolving, and what we know today may be just the beginning of a much larger story.

If you're struggling with depression or other mental health challenges, don't hesitate to seek professional help. The insights from microbiome research complement, rather than replace, traditional mental health treatments. A holistic approach that addresses both brain and gut health may offer the most comprehensive path to healing.

Here's to a future where mental health care is as personalized and precise as the unique microbiome within each of us! 🌱🧠💚

Further Reading

For those eager to dive deeper into this fascinating topic, here are some excellent resources:

  1. "The Mind-Gut Connection" by Emeran Mayer A comprehensive exploration of the gut-brain axis and its implications for health and disease.

  2. "This Is Your Brain on Food" by Uma Naidoo How diet influences brain function and mental health, with a focus on the gut-brain connection.

  3. "The Psychobiotic Revolution" by Scott C. Anderson, John F. Cryan, and Ted Dinan The definitive guide to psychobiotics and their potential in mental health treatment.

  4. "Gut: The Inside Story of Our Body's Most Underrated Organ" by Giulia Enders An accessible introduction to gut health and its impact on overall well-being.

  5. "The Good Gut: Taking Control of Your Weight, Your Mood, and Your Long-Term Health" by Justin Sonnenburg and Erica Sonnenburg Insights into how gut bacteria influence weight, mood, and health.

  6. "Microbiome and Mental Health" - Special issue in Biological Psychiatry (2020) Cutting-edge research on the microbiome's role in psychiatric disorders.

References

  1. Cryan, J. F., O'Riordan, K. J., Cowan, C. S. M., Sandhu, K. V., Bastiaanssen, T. F. S., Boehme, M., ... & Dinan, T. G. (2019). The microbiota-gut-brain axis. Physiological Reviews, 99(4), 1877-2013. https://journals.physiology.org/doi/full/10.1152/physrev.00018.2018

  2. Jiang, H., Ling, Z., Zhang, Y., Mao, H., Ma, Z., Yin, Y., ... & Ruan, B. (2015). Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behavior, and Immunity, 48, 186-194. https://www.sciencedirect.com/science/article/pii/S0889159115000884

  3. Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., ... & Raes, J. (2019). The neuroactive potential of the human gut microbiota in quality of life and depression. Nature Microbiology, 4(4), 623-632. https://www.nature.com/articles/s41564-018-0337-x

  4. Miller, A. H., & Raison, C. L. (2016). The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nature Reviews Immunology, 16(1), 22-34. https://www.nature.com/articles/nri.2015.5

  5. Yano, J. M., Yu, K., Donaldson, G. P., Shastri, G. G., Ann, P., Ma, L., ... & Hsiao, E. Y. (2015). Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell, 161(2), 264-276. https://www.cell.com/cell/fulltext/S0092-8674(15)00645-1

  6. Kelly, J. R., Borre, Y., O' Brien, C., Patterson, E., El Aidy, S., Deane, J., ... & Cryan, J. F. (2016). Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. Journal of Psychiatric Research, 82, 109-118. https://www.sciencedirect.com/science/article/pii/S0022395616302655

  7. Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., ... & Miller, A. H. (2013). A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiatry, 70(1), 31-41. https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1393353

  8. O'Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015). Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research, 277, 32-48. https://www.sciencedirect.com/science/article/pii/S0166432814006839

  9. Desbonnet, L., Garrett, L., Clarke, G., Bienenstock, J., & Dinan, T. G. (2008). The probiotic Bifidobacteria infantis: An assessment of potential antidepressant properties in the rat. Journal of Psychiatric Research, 43(2), 164-174. https://www.sciencedirect.com/science/article/pii/S0022395608001057

  10. Foster, J. A., & Neufeld, K. A. M. (2013). Gut–brain axis: how the microbiome influences anxiety and depression. Trends in Neurosciences, 36(5), 305-312. https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(13)00092-0

  11. Kappelmann, N., Lewis, G., Dantzer, R., Jones, P. B., & Khandaker, G. M. (2018). Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Molecular Psychiatry, 23(2), 335-343. https://www.nature.com/articles/mp2017113

  12. Clapp, M., Aurora, N., Herrera, L., Bhatia, M., Wilen, E., & Wakefield, S. (2017). Gut microbiota's effect on mental health: The gut-brain axis. Clinics and Practice, 7(4), 987. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641835/

  13. Mayer, E. A., Tillisch, K., & Gupta, A. (2015). Gut/brain axis and the microbiota. The Journal of Clinical Investigation, 125(3), 926-938. https://www.jci.org/articles/view/76304

  14. Dash, S., Clarke, G., Berk, M., & Jacka, F. N. (2015). The gut microbiome and diet in psychiatry: focus on depression. Current Opinion in Psychiatry, 28(1), 1-6. https://journals.lww.com/co-psychiatry/Abstract/2015/01000/The_gut_microbiome_and_diet_in_psychiatry___focus.2.aspx

  15. Liu, R. T., Walsh, R. F., & Sheehan, A. E. (2019). Prebiotics and probiotics for depression and anxiety: A systematic review and meta-analysis of controlled clinical trials. Neuroscience & Biobehavioral Reviews, 102, 13-23. https://www.sciencedirect.com/science/article/pii/S0149763419300508

  16. Jacka, F. N., O'Neil, A., Opie, R., Itsiopoulos, C., Cotton, S., Mohebbi, M., ... & Berk, M. (2017). A randomised controlled trial of dietary improvement for adults with major depression (the 'SMILES' trial). BMC Medicine, 15(1), 23. https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0791-y

  17. Firth, J., Marx, W., Dash, S., Carney, R., Teasdale, S. B., Solmi, M., ... & Sarris, J. (2019). The effects of dietary improvement on symptoms of depression and anxiety: a meta-analysis of randomized controlled trials. Psychosomatic Medicine, 81(3), 265-280. https://journals.lww.com/psychosomaticmedicine/Abstract/2019/04000/The_Effects_of_Dietary_Improvement_on_Symptoms_of.6.aspx

  18. Sarkar, A., Lehto, S. M., Harty, S., Dinan, T. G., Cryan, J. F., & Burnet, P. W. (2016). Psychobiotics and the manipulation of bacteria–gut–brain signals. Trends in Neurosciences, 39(11), 763-781. https://www.cell.com/trends/neurosciences/fulltext/S0166-2236(16)30118-6

  19. Winter, G., Hart, R. A., Charlesworth, R. P., & Sharpley, C. F. (2018). Gut microbiome and depression: what we know and what we need to know. Reviews in the Neurosciences, 29(6), 629-643. https://www.degruyter.com/document/doi/10.1515/revneuro-2018-0002/html

  20. Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., ... & Xie, P. (2016). Gut microbiome remodeling induces depressive-like behaviors through a pathway mediated by the host's metabolism. Molecular Psychiatry, 21(6), 786-796. https://www.nature.com/articles/mp2015120

This article represents the current state of knowledge as of 2024. As research in this field progresses rapidly, new findings may emerge that further illuminate the complex relationships between depression, the microbiome, inflammation, and serotonin production.